Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of ...

Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...

A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...

Discover how excess weight silently damages your joints through both mechanical stress and inflammation, and learn effective ...

Suzuki, R. (2025) Evaluation of the Hair Growth-Promoting Effects of Combined Treatment with Hair Growth Stimulants. Health, ...

The amended merger agreement was unanimously recommended and approved by the disinterested directors of each company's Board. As previously announced, Stockholders representing approximately 62% of ...

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with T2D.

Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

Watermelon is more than just a summer treat—it's a powerhouse of hydration, nutrients, and antioxidants. With its high water ...

The Nintendo Switch 2 has better graphics than the original, but it's notably more expensive and will launch with only a ...

Discover the truth about muscle loss with age, including when it actually begins and the proven strategies that can reverse ...